Needham & Company LLC upgraded shares of Core Scientific (NASDAQ:CORZ – Free Report) from a hold rating to a buy rating in a research note released on Tuesday morning, Marketbeat Ratings reports. They currently have $23.00 price objective on the stock.
CORZ has been the subject of several other reports. Keefe, Bruyette & Woods upped their target price on Core Scientific from $19.00 to $25.00 and gave the company a “moderate buy” rating in a research note on Tuesday, January 27th. Cantor Fitzgerald lowered their price target on Core Scientific from $26.00 to $25.00 and set an “overweight” rating for the company in a report on Tuesday. BTIG Research upgraded shares of Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price objective on the stock in a report on Tuesday, January 6th. HC Wainwright reissued a “buy” rating and issued a $25.00 target price on shares of Core Scientific in a research report on Tuesday. Finally, Zacks Research raised shares of Core Scientific from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 13th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $24.84.
Check Out Our Latest Research Report on CORZ
Core Scientific Price Performance
Core Scientific (NASDAQ:CORZ – Get Free Report) last issued its quarterly earnings results on Monday, March 2nd. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.69. The business had revenue of $79.76 million during the quarter, compared to analyst estimates of $118.45 million. During the same quarter last year, the firm posted ($0.69) earnings per share. The company’s revenue was down 16.0% on a year-over-year basis. As a group, sell-side analysts expect that Core Scientific will post 0.52 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of CORZ. AQR Capital Management LLC boosted its position in shares of Core Scientific by 106.1% in the first quarter. AQR Capital Management LLC now owns 283,432 shares of the company’s stock worth $2,052,000 after buying an additional 145,905 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Core Scientific by 180.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,109,387 shares of the company’s stock worth $8,032,000 after acquiring an additional 714,388 shares during the period. Nisa Investment Advisors LLC grew its position in Core Scientific by 192.3% in the second quarter. Nisa Investment Advisors LLC now owns 4,662 shares of the company’s stock valued at $80,000 after acquiring an additional 3,067 shares in the last quarter. Teacher Retirement System of Texas raised its stake in shares of Core Scientific by 31.4% during the second quarter. Teacher Retirement System of Texas now owns 42,543 shares of the company’s stock valued at $726,000 after purchasing an additional 10,161 shares during the period. Finally, Amalgamated Bank raised its stake in shares of Core Scientific by 52.2% during the second quarter. Amalgamated Bank now owns 9,423 shares of the company’s stock valued at $161,000 after purchasing an additional 3,231 shares during the period.
More Core Scientific News
Here are the key news stories impacting Core Scientific this week:
- Positive Sentiment: HC Wainwright reiterated a Buy, materially raised FY2026 EPS (from $0.16 to $0.33) and published quarterly EPS estimates with a $25 price target — a clear analyst endorsement that supports the rally. HC Wainwright Reiterates Buy
- Positive Sentiment: Canaccord raised its price target from $17 to $20 and maintained a Buy rating, adding upward price-target momentum. Canaccord PT Raised to $20
- Positive Sentiment: MarketBeat and other coverage argue the company’s pivot to AI colocation (including a reported $10B+ backlog and rapid colocation growth) creates multi-year upside and institutional buying support, which can drive investor interest despite short-term churn. Core Scientific’s $10 Billion AI Shift
- Neutral Sentiment: CoreWeave contract progress: reports note the CoreWeave deal is ahead of schedule and colocation revenue is ramping, a structural positive; however, this is balanced by transitional revenue mix changes. CoreWeave Deal Ahead of Schedule
- Neutral Sentiment: Short-interest data in recent filings shows anomalous “0 shares” readings (likely a reporting glitch); current days-to-cover appears negligible — this item is noisy and should not be overinterpreted.
- Negative Sentiment: Q4 2025 results showed revenue weakness (reported as a 38% YoY decline in one summary) and a sharp earnings swing tied to the pivot, which earlier drove a significant intraday drop. Investors remain sensitive to near-term top-line contraction and negative adjusted EBITDA while expansion investments continue. Core Scientific 2025 earnings: revenue falls 38% YoY
- Negative Sentiment: At least one firm (Ladenburg Thalmann) lowered expectations, reflecting some analyst caution on near-term execution risks and balance-sheet concerns tied to the transition. Ladenburg Lowers Expectations
About Core Scientific
Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.
Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.
Further Reading
- Five stocks we like better than Core Scientific
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
